Search

Ravi P Anantha

from North Potomac, MD
Age ~54
Get Report
Also known as:
Ravi Prakash Anantha
Phone and address:
205 Lee St, Gaithersburg, MD 20877
Related to:
Vundavalli L Anantha, 81Zoe S Anantha, 28Ramesh K Anantha, 57Melissa D Anantha, 55Zoe Sita Anantha, 30Tess A AnanthaNarasipur G Anantha, 91Jake R Anantha
Connected to:
Balamurali Ananthan, 45Hari K Ananth, 35Hariharan Ananthanarayana, 43Krishnan Anantha, 48Satish B Ananthanarayana, 48Savitha M Anantharaman, 53Sharath Ananth, 50Sreeraman Anantharaman, 43Akhila S Ananthram, 30Praveen Ananthula, 45

Ravi Anantha Phones & Addresses

  • 205 Lee St, Gaithersburg, MD 20877
  • North Potomac, MD
  • 836 Lombard St, Baltimore, MD 21201
  • 214 Scott St, Baltimore, MD 21230
  • 754 Bridgeman Ter, Towson, MD 21204
  • Cockeysville, MD
  • Hopewell Jct, NY
  • 99 Golden Ash Way, Gaithersburg, MD 20878

Work

Company: Emergent biosolutions Sep 2018 Position: Senior manager, in vivo testing

Education

Degree: Doctorates, Doctor of Philosophy School / High School: University of Maryland - Baltimore 1993 to 2000 Specialities: Molecular Biology

Skills

Biotechnology • Molecular Biology • Immunology • Life Sciences • Cell Culture • Drug Discovery • Biopharmaceuticals • Vaccines • Cell • Pcr • Lifesciences • Assay Development • Flow Cytometry • Western Blotting • Elisa • Glp

Industries

Biotechnology

Resumes

Resumes

Ravi Anantha Photo 1

Senior Manager, In Vivo Testing

View page
Location:
Washington, DC
Industry:
Biotechnology
Work:
Emergent Biosolutions
Senior Manager, In Vivo Testing
Universal Solutions International Inc. Nov 2017 - Sep 2018
Subject Matter Expert
Aeras 2011 - Dec 2016
Associate Director
Aeras 2006 - 2010
Senior Scientist
Aeras Dec 2005 - 2008
Scientist
Education:
University of Maryland - Baltimore 1993 - 2000
Doctorates, Doctor of Philosophy, Molecular Biology The Johns Hopkins University 1988 - 1992
Bachelors, Bachelor of Arts, Biology John Jay High School
Skills:
Biotechnology
Molecular Biology
Immunology
Life Sciences
Cell Culture
Drug Discovery
Biopharmaceuticals
Vaccines
Cell
Pcr
Lifesciences
Assay Development
Flow Cytometry
Western Blotting
Elisa
Glp

Publications

Us Patents

Methods To Increase Transgene Expression From Bacterial-Based Delivery Systems By Co-Expressing Suppressors Of The Eukaryotic Type I Interferon Response

View page
US Patent:
7883696, Feb 8, 2011
Filed:
Sep 11, 2009
Appl. No.:
12/558137
Inventors:
Jerald C. Sadoff - Washington DC, US
Mohamad F. Jamiluddin - Frederick MD, US
Ravi P. Anantha - Gaithersburg MD, US
Assignee:
Aeras Global TB Vaccine Foundation - Rockville MD
International Classification:
A61K 48/00
C07K 14/00
C07H 21/04
US Classification:
424 932, 424 931, 424 934, 4241851, 4242341, 4242481, 536 231, 536 237
Abstract:
Bacterial delivery systems with improved transgene expression are provided. The recombinant bacterial delivery systems deliver transgenes of interest and suppressors of the eukaryotic Type I interferon response to eukaryotic cells. Suppression of the eukaryotic Type I interferon response allows improved expression of the encoded transgene.

Methods To Increase Transgene Expression From Bacterial-Based Delivery Systems By Co-Expressing Suppressors Of The Eukaryotic Type I Interferon Response

View page
US Patent:
8414884, Apr 9, 2013
Filed:
Dec 10, 2010
Appl. No.:
12/964830
Inventors:
Jerald C. Sadoff - Washington DC, US
Mohamad F. Jamiluddin - Frederick MD, US
Ravi P. Anantha - Gaithersburg MD, US
Assignee:
Aeras Global TB Vaccine Foundation - Bethesda MD
International Classification:
A61K 48/00
A61K 39/00
A01N 63/00
US Classification:
424 932, 424 931, 4241841, 4242341, 530351
Abstract:
Bacterial delivery systems with improved transgene expression are provided. The recombinant bacterial delivery systems deliver transgenes of interest and suppressors of the eukaryotic Type I interferon response to eukaryotic cells. Suppression of the eukaryotic Type I interferon response allows improved expression of the encoded transgene.

Methods To Increase Transgene Expression From Bacterial-Based Delivery Systems By Co-Expressing Suppressors Of The Eukaryotic Type I Interferon Response

View page
US Patent:
20090068222, Mar 12, 2009
Filed:
Sep 12, 2007
Appl. No.:
11/854027
Inventors:
Jerald C. Sadoff - Washington DC, US
Mohamad F. Jamiluddin - Frederick MD, US
Ravi P. Anantha - Gaithersburg MD, US
International Classification:
A61K 39/00
C12N 1/20
A61P 37/00
C12N 15/74
US Classification:
4242001, 4352523, 435471
Abstract:
Bacterial delivery systems with improved transgene expression are provided. The recombinant bacterial delivery systems deliver transgenes of interest and suppressors of the eukaryotic Type I interferon response to eukaryotic cells. Suppression of the eukaryotic Type I interferon response allows improved expression of the encoded transgene.

Methods To Increase Transgene Expression From Bacterial-Based Delivery Systems By Co-Expressing Suppressors Of The Eukaryotic Type I Interferon Response

View page
US Patent:
20130224242, Aug 29, 2013
Filed:
Apr 8, 2013
Appl. No.:
13/858289
Inventors:
Jerald C. Sadoff - Washington DC, US
Mohamad F. Jamiluddin - Frederick MD, US
Ravi P. Anantha - Gaithersburg MD, US
Assignee:
Aeras Global TB Vaccine Foundation - Bethesda MD
International Classification:
A61K 39/00
A61K 39/12
A61K 39/04
US Classification:
4242001
Abstract:
Bacterial delivery systems with improved transgene expression are provided. The recombinant bacterial delivery systems deliver transgenes of interest and suppressors of the eukaryotic Type I interferon response to eukaryotic cells. Suppression of the eukaryotic Type I interferon response allows improved expression of the encoded transgene.
Control profile
Ravi P Anantha from North Potomac, MD, age ~54 Get Report